Navigation Links
VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009
Date:11/4/2009

patients with type 2 diabetes in combination with other diabetes medications.

About VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease. VIA's lead candidate, VIA-2291, targets a significant unmet medical need by reducing inflammation in plaque, which is an underlying cause of atherosclerosis and its complications, including heart attack and stroke. In addition, VIA's pipeline of drug candidates includes other compounds to address other underlying causes of cardiovascular disease: high cholesterol, diabetes and inflammation. For more information, visit: http://www.viapharmaceuticals.com.

Forward Looking Statements

This press release may contain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or to VIA's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause VIA's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue" or the negative of these terms or other comparable terminology. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond VIA's control and which could materially affect actual results, levels of activity, performance or achievements.

Factors that may cause actu
'/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Reportlinker Adds Gastrointestinal Pharmaceuticals: Technologies and Markets
2. Peregrine Pharmaceuticals Regains Full Compliance With Nasdaq Continued Listing Requirements
3. Isis Pharmaceuticals to Present at the 2009 Canaccord Adams Cardiovascular Conference
4. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
5. Quark Pharmaceuticals to Present Data on its siRNA Therapeutic Programs in Kidney and Lung Diseases
6. Warner Chilcott Completes Acquisition of P&Gs Global Branded Prescription Pharmaceuticals Business
7. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
8. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
9. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
10. Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance
11. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... -- Nektar Therapeutics (Nasdaq: NKTR ) will announce ... 30, 2014 on Thursday, November 6, 2014, after the ... president and chief executive officer, will host a conference ... Eastern Time (ET)/2:00 p.m. Pacific Time (PT). ... of the conference call can be accessed through a ...
(Date:10/30/2014)... BOTHELL, Wash. , Oct. 30, 2014   ... a leading developer, manufacturer and marketer of proprietary clinical ... media and precision thermal shipping products ... Company,s third quarter 2014 financial results will be released ... will host a conference call and live webcast at ...
(Date:10/30/2014)... 30, 2014 Extensiv ... Aufbau von Kuhmilchverträglichkeit     Kuhmilchproteinallergie (KMPA) ... Säuglingen und Kleinkindern. Der bisher übliche Umgang ... der Babys bzw. deren stillenden Mütter Milchproteine ... sich bei einer beträchtlichen Anzahl von Kindern ...
Breaking Medicine Technology:Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets 2BioLife Solutions to Report Financial Results for Third Quarter 2014 and Provide Business Update on November 6, 2014 2Experten präsentieren neuste Forschungsergebnisse auf dem Allergy Day 2Experten präsentieren neuste Forschungsergebnisse auf dem Allergy Day 3
... Pharmaceuticals, a specialty pharmaceutical company based in Atlanta, ... the company as General Counsel and Chief Compliance ... and most recently held positions of increasing responsibility ... at Shionogi, Leslie built the company,s legal department ...
... Mass., Feb. 21, 2012 UV Flu Technologies, Inc. ... in its 1st quarter report, filed on February 16, 2012, ... for the last 12 months, with another 20% reduction in ... sales and gross profits.  On February 3, 2012, the Company ...
Cached Medicine Technology:Leslie Zacks Joins Arbor Pharmaceuticals as General Counsel and Chief Compliance Officer 2UV Flu Technologies Continues Progress on Numerous Fronts 2UV Flu Technologies Continues Progress on Numerous Fronts 3
(Date:10/30/2014)... Home Care Assistance – Halton/Peel Region ( http://www.GreaterTorontoHomeCare.ca ... care, is weighing in on a recent study linking ... performed by the University of Illinois, analyzed 88 patients ... week-long period and observed how much time was spent ... the structural soundness of the white matter in each ...
(Date:10/30/2014)... Jacksonville, FL (PRWEB) October 30, 2014 ... non-profit offering therapeutic horseback riding to special needs individuals ... Annual Round-Up on Saturday, November 15 from 10-2:00 p.m. ... fun event is open to the public and is ... programs. , Admission to the HSS Round-Up is ...
(Date:10/30/2014)... Fort Lauderdale, FL (PRWEB) October 30, 2014 ... leading US Joint Commission Accredited teleradiology and specialty ... today that in addition to its existing teleradiology ... adding multispecialty second opinion and expert telemedicine services, ... Houston, Texas. , As a result of this ...
(Date:10/30/2014)... The human brain is often overlooked ... to help maintain better mental health, according to Dr. ... Lose Your Memory in 100 Ways’ for just that ... conflicting attitudes to help keep the reader constantly thinking. ... must decipher the hidden logic within. , “If you ...
(Date:10/30/2014)... October 30, 2014 Victory Healthcare, ... its 2014 third quarter infection rates and patient ... infection rates of only two percent or less, ... scores exceeding 98 percent. , “We are delighted ... included rising satisfaction scores,” said Robert Helms, chairman ...
Breaking Medicine News(10 mins):Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 2Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 3Health News:Horse Sense & Sensitivity, Jacksonville Non-profit, To Hold 2nd Annual Round-Up 2Health News:USARAD HOLDINGS INC, SECONDOPINIONS.COM® Pioneers Specialty On-Demand Telemedicine And Second Opinion Service At Houston-Based, Mission Bend Freestanding ER Chain 2Health News:USARAD HOLDINGS INC, SECONDOPINIONS.COM® Pioneers Specialty On-Demand Telemedicine And Second Opinion Service At Houston-Based, Mission Bend Freestanding ER Chain 3Health News:‘Dementia Express’ Offers Contradictory and Sometimes Reverse Thinking, All to Keep its Reader on Their Toes With an Active Mind. 2Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 2Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 3
... , , ... ) announced today that it has named Andrew J. Sussman, M.D., ... health clinic subsidiary, and as Senior Vice President/Associate Chief Medical Officer ... be responsible for all clinical services and daily operations for MinuteClinic,s ...
... ... ... hundreds of dollars on new digital hearing aids need look no further. ... utilizes a nationwide network of more than 1,200 professionals and offers discounts on a wide ...
... , MAITLAND, Fla. , July 28 ... treatment for infants with plagiocephaly and other head shape abnormalities, opened ... The Center currently also has offices in the Baltimore and Dallas ... orthoses, also commonly referred to as a cranial helmets or headbands. ...
... REDWOOD CITY, Calif., July 28 Genomic Health, Inc. (Nasdaq: ... call and webcast on Tuesday, August 4, 2009 at 4:30 p.m. Eastern ... and webcast will follow the release of the second quarter financial results ... , To access the live conference call on August ...
... , , , , ... for Rainbow Hospice and Palliative Care at the historic ... Tickets are limited to the first 1,500 people. Tickets for the event, billed as ... food stations, are just $75. Grammy nominated band and Villa Park natives the ...
... Increases 2009 Guidance for Eligard(R) Sales and Adjusted EBITDA , ... QLTI ; TSX: QLT) ("QLT" or the "Company") ... 30, 2009. Unless specified otherwise, all amounts are in U.S. ... pleased to report another strong financial quarter, with robust Eligard(R) ...
Cached Medicine News:Health News:CVS Caremark Names Andrew J. Sussman, M.D., as President/Chief Operating Officer of MinuteClinic 2Health News:CVS Caremark Names Andrew J. Sussman, M.D., as President/Chief Operating Officer of MinuteClinic 3Health News:Hearing Aid Savings Galore 2Health News:New STAR Cranial Center of Excellence Offers Cutting-Edge Treatment to Central Florida Infants 2Health News:New STAR Cranial Center of Excellence Offers Cutting-Edge Treatment to Central Florida Infants 3Health News:New STAR Cranial Center of Excellence Offers Cutting-Edge Treatment to Central Florida Infants 4Health News:New STAR Cranial Center of Excellence Offers Cutting-Edge Treatment to Central Florida Infants 5Health News:Genomic Health to Announce Second Quarter 2009 Financial Results and Host Conference Call on Tuesday, August 4, 2009 2Health News:Plain White T's to Headline Lake Effect Benefit for Rainbow Hospice and Palliative Care at Palmer House, Friday, August 28th 2Health News:Plain White T's to Headline Lake Effect Benefit for Rainbow Hospice and Palliative Care at Palmer House, Friday, August 28th 3Health News:QLT Announces Second Quarter Results for 2009 2Health News:QLT Announces Second Quarter Results for 2009 3Health News:QLT Announces Second Quarter Results for 2009 4Health News:QLT Announces Second Quarter Results for 2009 5Health News:QLT Announces Second Quarter Results for 2009 6Health News:QLT Announces Second Quarter Results for 2009 7Health News:QLT Announces Second Quarter Results for 2009 8Health News:QLT Announces Second Quarter Results for 2009 9Health News:QLT Announces Second Quarter Results for 2009 10Health News:QLT Announces Second Quarter Results for 2009 11Health News:QLT Announces Second Quarter Results for 2009 12Health News:QLT Announces Second Quarter Results for 2009 13Health News:QLT Announces Second Quarter Results for 2009 14Health News:QLT Announces Second Quarter Results for 2009 15Health News:QLT Announces Second Quarter Results for 2009 16Health News:QLT Announces Second Quarter Results for 2009 17
... Titanium Cranial Fixation Systems incorporate a ... requested by surgeons and surgical staff. ... may be either shaped on the ... a pre-measured, cut, bent and shaped ...
Specially designed combination of demineralized bone fibers and demineralized bone cubes that are both osteoinductive and osteoconductive. Packs well into bone defects. Eliminates the need to mix can...
... matrix and conductive cancellous chips. ... be free of foreign matter. ... is 125 to 1000 . ... 1 - 8 mm. 5:3 ...
Demineralized cortical fibers and cancellous chips....
Medicine Products: